Anavex Life Sciences Corp.AVXLNASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank73
3Y CAGR-7.2%
5Y CAGR+1.2%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-7.2%/yr
vs +18.0%/yr prior
5Y CAGR
+1.2%/yr
Recent deceleration
Acceleration
-25.1pp
Decelerating
Percentile
P73
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
3 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $44.60M | -13.2% |
| 2025 | $51.41M | -2.8% |
| 2024 | $52.88M | -5.2% |
| 2023 | $55.76M | +9.4% |
| 2022 | $50.99M | +21.4% |
| 2021 | $42.00M | +35.8% |
| 2020 | $30.94M | +7.4% |
| 2019 | $28.81M | +50.2% |
| 2018 | $19.18M | +23.5% |
| 2017 | $15.54M | - |